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Murine cytomegalovirus (MCMV) Smith strain has been cloned as a bacterial artificial chromosome (BAC)
named pSM3fr and used for analysis of virus gene functions in vitro and in vivo. When sequencing the complete
BAC genome, we identified a frameshift mutation within the open reading frame (ORF) encoding MCMV
chemokine homologue MCK-2. This mutation would result in a truncated MCK-2 protein. When mice were
infected with pSM3fr-derived virus, we observed reduced virus production in salivary glands, which could be
reverted by repair of the frameshift mutation. When looking for the source of the mutation, we consistently
found that virus stocks of cell culture-passaged MCMV Smith strain are mixtures of viruses with or without
the MCK-2 mutation. We conclude that the MCK-2 mutation in the pSM3fr BAC is the result of clonal
selection during the BAC cloning procedure.
Herpesviruses cloned as bacterial artificial chromosomes
(BACs) have opened a new era of analysis of herpesviral gene
functions (48). The major advantage to conventional virus mu-
tagenesis by homologous recombination in cell culture is the
fast mutagenesis and clonal propagation in bacteria.
When a virus is cloned as a BAC, the growth of reconstituted
virus in cell culture and, if possible, spread in animals, are
compared to those of the parental wild-type virus. If these
parameters are comparable and genome organization is iden-
tical, the BAC-cloned virus is commonly defined as wild type-
like (2, 4, 44, 47). For murine cytomegalovirus (MCMV) and
also murine gammaherpesvirus 68 (MHV-68), whose growth
phenotypes can also be tested in animals, it was soon recog-
nized that insertion of a BAC cassette attenuated the virus in
vivo. For both viruses, strategies were developed to remove the
BAC cassette (1, 47). Thus, the in vivo wild-type growth char-
acteristics could be restored.
The MCMV BAC pSM3fr cloned from MCMV Smith strain
is the prototype of BAC-cloned MCMV (30, 47). It has been
shown to infect newborn mice like wild-type Smith strain (47).
Since then, it has been used by several groups to study MCMV
biology in vitro and in vivo. Mutations were introduced in
pSM3fr, and the properties of reconstituted mutants were
compared to those of the parental virus reconstituted from
pSM3fr (named C3X or MW97.01) (6, 15, 19, 32, 35, 49).
Here, we show that after infection of adult BALB/c mice,
pSM3fr-derived virus showed a defect in virus production in
salivary glands and that this was due to a frameshift mutation
in the MCMV MCK-2 open reading frame (ORF). MCK-2 is
a CC() chemokine homologue which is thought to be in-
volved in the recruitment of leukocyte subsets that serve as
vehicles for viral dissemination (17, 27, 39). In the MCMV
wild-type strains Smith and K181, the MCK-2 ORF codes for
a 280-amino-acid-long protein. In the pSM3fr-derived virus,
the MCK-2 frameshift mutation would shorten the protein by
144 C-terminal amino acids. Repair of the frameshift mutation
restored high titers in the salivary glands of mice infected with
pSM3fr-derived virus. We could show that cell culture-pas-
saged MCMV Smith strain is consistently a mixture of viruses
with intact or mutant MCK-2 ORFs and that after passage
through salivary glands of BALB/c mice, the MCK-2 mutant
genomes are suppressed. Thus, we propose that cloning of the
pSM3fr BAC has selected a MCK-2 mutant genome resulting
in the observed growth phenotype in salivary glands. We pro-
pose to routinely sequence BAC-cloned viruses.
MATERIALS AND METHODS
Cells and viruses. Primary mouse embryonal fibroblasts (MEF) from BALB/c
mice, M2-10B4 cells (CRL-1972; ATCC), and NIH 3T3 cells (CRL-1658; ATCC)
were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with either 5 or 10% fetal calf serum, 100 units/ml penicillin, and 100
units/ml streptomycin.
Wild-type MCMV Smith and K181 strains have been propagated in MEF or
M2-10B4 cells. pSM3fr-derived virus is a BAC-derived virus which was cloned
from MCMV Smith strain (47). VpSM3fr-m157-M27 is derived from a
pSM3fr mutant with deletions of m157 and M27 (38).
Mice and infection. Female BALB/c mice were either purchased from Elevate
Janvier (Le Genest Saint Isle, France) at the age of 5 weeks and housed at the
animal facility of the Max von Pettenkofer-Institute (University of Munich) for
at least 1 week before use in experiments or were bred at the Department for
Histology and Embryology (University of Rijeka, Croatia) and used at the age of
10 to 12 weeks. All animals were kept under specific-pathogen-free (SPF) con-
ditions. The mice were infected intraperitoneally (i.p.) or intravenously (i.v.) with
3  105 50% tissue culture infective doses (TCID50) of MCMV in a volume of
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500 l, or the mice were infected in the right hind footpad with 1.5  106 TCID50
in a volume of 25 l. Virus titers in organs were determined as described
previously (11). Animal experiments were approved by the responsible office of
the State of Bavaria or by the Ethics Committee of the Medical Faculty, Uni-
versity of Rijeka.
454 sequencing of BAC-cloned MCMV. pSM3fr, pSM3fr-m157-M27, and
pSM3fr-loxP DNA (38, 47) from Escherichia coli were prepared using the
NucleoBond AX kit (Macherey-Nagel, Du¨ren, Germany) following the manu-
facturer’s instructions. DNA was digested with at least three restriction enzymes
and run on an 0.8% agarose gel to control integrity. Virus particles were purified
on a linear Nycodenz gradient (Axis-shield PoC, AS, Oslo, Norway) as described
previously (14). Virion DNA was isolated (13) and tested for integrity and purity
by restriction enzyme digestion. Emulsion PCR was performed as described
elsewhere (26), and 454 sequencing was carried out on the Roche 454 FLX and
titanium platforms.
Sequencing of PCR-amplified viral sequences. BAC DNA isolated from E. coli
as described above or viral DNA isolated from infected cells, organs, or cell
culture supernatants using the DNeasy blood and tissue kit (Qiagen) were used
as templates to amplify fragments containing the sequence deviations from
MCMV Smith strain observed for pSM3fr. The primer pairs used for amplifica-
tion are listed in Table 1. These fragments then served as templates for subse-
quent sequencing.
BAC mutagenesis of the MCK-2 locus. Markerless BAC mutagenesis was
performed to introduce changes in the MCK-2 locus as described previously
(23, 45). Briefly, an I-SceI-aphAI cassette was amplified from the plasmid
pEPKAN-S by PCR using primers m129repair-for (5-ACAGACACACTCT
ATCCAGTTTTCACCGTCCTTCACCTCGTAGGGGTACTTGCCCACCG
TGAGGATGACGACGATAAGTAGGG-3) and m129repair-rev (5-GAT
GACGGAATCGCCACGCATCACGGTGGGCAAGTACCCCTACGAGG
TGAAGGACGGTGAAACAACCAATTAACCAATTCTGATTAG-3). In
the first Red recombination, this PCR fragment was inserted in pSM3fr, result-
ing in a BAC carrying a kanamycin resistance cassette flanked by an I-SceI
restriction site. The kanamycin resistance cassette was then removed from kana-
mycin-resistant clones by an I-SceI digestion and a subsequent Red recombina-
tion, resulting in a markerless insertion of a T  A base pair at position 187786 of
the MCMV Smith strain. The resulting BACmid was called pSM3fr-MCK-2fl (fl
stands for full-length).
Deletions and insertions were controlled by restriction pattern analysis and
subsequent sequencing.
Reconstitution of virus from recombinant BACs and preparation of virus
stocks. BACs were reconstituted to virus by transfection of BAC DNA into MEF
using Superfect transfection reagent (Qiagen, Germany) according to the man-
ufacturer’s instructions. Transfected cells were propagated until viral plaques
appeared, and supernatants from these cultures were used for further propaga-
tion.
Virus stocks were prepared by pelleting virus from supernatants of infected
M2-10B4 cells (26,000  g for 3 h), and the pellets were resuspended in VSB
buffer (0.05 M Tris-HCl, 0.012 M KCl, and 0.005 M EDTA, adjusted to pH 7.8)
and then purified by centrifugation through a 15% sucrose cushion in VSB buffer
(53,000  g).
Virus titers of stocks were determined by a TCID50 assay performed on MEF
on 96-well plates.
RESULTS
Sequence divergency of pSM3fr and pSM3fr-derived virus.
When we infected adult BALB/c mice with BAC (pSM3fr)-
derived MCMV, only relatively low titers of virus were found
in the salivary glands. This was also shown by other groups (10,
12, 15, 21, 32) but was never addressed, although it stood in
marked contrast to the high salivary gland titers observed when
BALB/c mice were infected with MCMV strains not cloned as
BACs (17, 22, 28, 39). To find out whether this phenotype of
the pSM3fr-derived virus was due to genomic differences be-
tween the MCMV Smith strain and the pSM3fr genome, we
sequenced the complete genomes of pSM3fr, two independent
pSM3fr-derived mutants (pSM3fr-m157-M27 and pSM3fr-
loxP) and a virus stock derived from pSM3fr-m157-M27.
Both pSM3fr-derived mutants had undergone two consecutive
targeted deletions of either m157 and M27 or the two lox-P
sites in pSM3fr as described before (38). The virus stock has
been passaged 6 times on MEF. Table 2 shows deviations
from the BAC-cloned genomes to the published sequence of
MCMV Smith strain (36). Since the EcoRI digestion frag-
ments O, b, f, and g, comprising the ORFs m151 to m158 in the
BAC-cloned genomes were derived from MCMV strain K181
introduced during the BAC cloning procedure (29, 47), this
region was excluded from the analysis. Only divergency which
was found in at least two of the four sequences and which lead
to changes in the amino acid composition of viral proteins was
considered. In total, 22 positions of sequence divergency to the
published MCMV Smith sequence could be found, affecting 15
ORFs, most of them in accordance with previously published
data (3, 5, 9, 16, 25, 41, 46). Many sequence deviations of the
pSM3fr sequence reported by us and others (41) presumably
are sequence failures of the deposited MCMV Smith strain
sequence. When we sequenced PCR-amplified fragments of
MCMV Smith strain-derived DNA (ATCC-VR-1399) cover-
ing these positions, we found the same deviations from the
published Smith strain sequence (Table 2, group B). Overall,
the sequencing data show that the pSM3fr sequence and the
TABLE 1. PCR primers used to amplify viral gene fragments
Gene Primerdirection Primer sequence
M12 Forward 5-CCGCGAATAAACAAGTGGAT-3
Reverse 5-AGATTTTCGTCCGTGACT-3
M45 Forward 5-GAGACGATGGCGGTGTAGAG-3
Reverse 5-GGGAGACGACGAAGATCAGT-3
M49 Forward 5-GTGTGATTGCCCTCCAACTT-3
Reverse 5-TTTCGTCGAACGCTACTGTC-3
M58 Forward 5-TCACAATCCTCACGCAAGC-3
Reverse 5-TGCTACGAGACCACAAATCG-3
M86 Forward 5-GGGTAGCGGAAGAACTCCAG-3
Reverse 5-CGTGAGCCAGAACATCAACA-3
M102 Forward 5-GAGGCACTTTCGCATCAAC-3
Reverse 5-ACGCGCTTGCAGATGTAGTT-3
m107 Forward 5-TGTCCGATGCGATCAAGTAA-3
Reverse 5-TGCGGATGTTCAACCTAGTG-3
m117.1 Forward 5-GCATGAAAGGCAGAGGTAGC-3
Reverse 5-CGTGCTGCTTAGCGTTTTTA-3
M119.1 Forward 5- TCGATCCATAGTCCCGAAAG-3
Reverse 5-AAGTGACGGAACCCACTGAG-3
M122 Forward 5-CAGAGGGAGGTGTGAAAGGA-3
Reverse 5-TGAGAGTGAGGCAGATGAGG-3
m129/1 Forward 5-GGGGCGCGATAGGGGGTGTC-3
Reverse 5-GAAGTCTAACAATCTCTCGG-3
m129/2 Forward 5-TGTGAGATCACCTGGGTCGG-3
Reverse 5-GTATGTCATGGTTTTTAATC-3
m131 Forward 5-GCTTAACGTTTCACTGATTC-3
Reverse 5-AGGACACGCAGTCTGGAATC-3
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Smith strain sequence are nearly identical, which once again
reveals that MCMV genomes are very stable during in vivo and
in vitro passage (8).
Restoration of the full-length MCK-2 ORF reversed the sali-
vary gland phenotype. Most interestingly, the major pSM3fr-
specific sequence deviation is a deletion of a T  A base pair
corresponding to position 187786 of the MCMV Smith strain
sequence. This frameshift results in a stop codon in the reading
frame of the chemokine homologue MCK-2 formed by the
ORFs m131 and m129 (37) and thus, would lead to a truncated
MCK-2 protein (Fig. 1). Moreover, infection of mice with
viruses having mutations and deletions of MCK-2 have been
shown to result in reduced numbers of infected peripheral
blood leukocytes (PBLs) and reduced titers in salivary glands,
whereas titers in other organs were not affected (17, 39, 40).
We hypothesized from this finding that the loss of the C-ter-
minal part of MCK-2 might be the cause for the attenuated
salivary gland phenotype of pSM3fr-derived virus.
The full-length MCK-2 ORF was restored by inserting a
T  A base pair at position 187786 of pSM3fr using a marker-
less mutagenesis protocol (23, 45). Two clones of pSM3fr-
MCK-2fl (full length) (clones 3.3 and 4.1) were reconstituted
to virus, and the virus was tested for its in vitro and in vivo
growth patterns. pSM3fr- and pSM3fr-MCK-2fl-derived viruses
showed comparable growth curves in NIH 3T3 cells infected at
a low multiplicity of infection (MOI) (Fig. 2), which was in
accordance with comparisons of the in vitro growth curves of
MCMV Smith strain and its MCK-2 mutants (17).
BALB/c mice were infected by the intraperitoneal route, and
virus titers were determined in organs 3, 8, and 14 days after
infection. The only obvious difference between the pSM3fr-
derived virus and the two MCK-2 full-length clones were ele-
vated virus titers in the salivary glands after restoration of
MCK-2 (Fig. 3A). This salivary gland phenotype could also be
observed when mice were infected in the periphery via foot-
pads (Fig. 3B). The low levels of salivary gland virus observed
for MCK-2 mutants are considered to be the result of a defi-
ciency in dissemination in the absence of an intact MCK-2 (17,
39). This hypothesis was strengthened by our finding that after
intravenous infection, the differences between salivary gland
titers of viruses with a full-length MCK-2 ORF and viruses with
a disrupted MCK-2 ORF were smaller (Fig. 3B). Here, the
route of virus administration already ensures dissemination via
the bloodstream.
TABLE 2. Differences between the Smith strain sequencea and pSM3fr sequence
Group and gene Position Mutation Change(s) in protein Reference(s)
Group A (sequence failures of the
deposited Smith sequence
identified before)
M20 20957 G Frameshift, ORF extended 25, 41
M29/m29.1 36198 G M29 frameshift, ORF truncated; m29.1 frameshift,
ORF extended
3, 41
M30 37260 C Frameshift, ORF extended 3, 41
M31 38803 G Frameshift, ORF extended 25, 41
m143 201403 G Frameshift, ORF extended 9, 41
Group B (sequence deviations of pSM3fr
that are due to sequence failures of
the deposited Smith sequence)
M45 61918 C Frameshift, fusion of M45 and m45.1 5, 41
M49 74719 T3C Ser2713 Gly271
M58 92088 A Protein sequence deviation from amino acid 110
to amino acid 220
41
92178 C3GCG Protein sequence deviation from amino acid 110
to amino acid 220
92206 CG3GC Protein sequence deviation from amino acid 110
to amino acid 220
92226 G3A Protein sequence deviation from amino acid 110
to amino acid 220
92230 G3A Protein sequence deviation from amino acid 110
to amino acid 220
92358 G Protein sequence deviation from amino acid 110
to amino acid 220
M86 123941 A3C Leu1107 3 Arg1107 41
123951 T3G Asn11043 His1104
m107/m108 162374 T3C m107 Leu1313 Pro131 m108 Ser1333 Gly133 16, 41
162380 T3C m107 Leu133 3Ser133 m108 Asn1313 Asp131
m117.1/m117 170652 A3C m117.1 Asp371 3Ala371 m117 Ser87 3 Ala87
Group C (sequence deviations of pSM3fr)
M12 12052 G3A Glu123 3 Lys123
M102 146853 G3A Asp420 3 Asn420 41
M122 Ex5 179136 G3A Ser227 3 Phe227 41
m129 187786 T Frameshift, ORF truncated 41
a The Smith strain sequence was deposited in GenBank under accession number NC_004065 (36).
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Cell culture-passaged MCMV Smith strain is a mixture of
genomes carrying intact or mutant MCK-2 ORFs. Cloning of
viruses as BACs involves a recombination step between the
viral genome and the BAC cassette in infected cells and a
subsequent transfer of the recombinant genomes to E. coli
followed by clonal propagation of transformed E. coli. We
wondered whether the MCK-2 mutation found in the pSM3fr
BAC was introduced into the MCMV genome during the BAC
cloning procedure or whether it was the result of clonal selec-
tion of a mutant preexisting in the virus inoculum used to infect
cells for integration of the BAC cassette. Therefore, we tested
whether MCMV Smith virus stocks are heterogeneous with
respect to their MCK-2 sequences. We prepared DNA from an
MCMV Smith virus stock originating from the time when the
pSM3fr BAC was cloned in our laboratory (ATCC-VR-194;
Smith strain Munich) and also from an MCMV Smith virus
stock recently sold by ATCC (ATCC-VR-1399; Smith strain
ATCC). Both virus stocks were derived from cells infected in
vitro. We amplified the MCK-2 sequence spanning the locus of
FIG. 1. Schematic presentation of the deletion found in the MCK-2 ORF of pSM3fr. The nucleotide sequence of MCK-2 exons and introns
is shown. The initiating methionine residues for the m131 and m129 ORFs and the intron sequence are circled and boxed, respectively. The inset
indicates the position of the T  A deletion at MCK-2 position 486 and the resulting stop mutation in pSM3fr.
FIG. 2. Comparison of growth of unrepaired and repaired pSM3fr-
derived viruses. Multistep growth curves of virus derived from pSM3fr
or pSM3fr-MCK-2fl clone 3.3 or 4.1 are shown. NIH 3T3 cells were
infected at an MOI of 0.1, and supernatants were harvested daily and
titrated. The titers of supernatants are expressed as TCID50 per ml.
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the mutation found in pSM3fr by PCR and subsequently se-
quenced the amplified fragments. We found that with respect
to the MCK-2 mutation, both virus stocks were mixtures (Fig.
4A). The electropherograms of the sequenced PCR products
showed differences in the proportions of wild-type and mutant
sequences for the selected stocks. In addition, we tested several
cell culture-derived Smith strain virus stocks from other labo-
ratories and found comparable mixtures for the MCK-2 mu-
tation as depicted in Fig. 4A (data not shown). When we
infected BALB/c mice with Smith strain ATCC and isolated
salivary gland virus, the proportion of the nonmutated MCK-2
sequence quickly increased in passage 1, and already after two
passages, the electropherograms no longer showed the mu-
tated sequence (Fig. 4B). When we recultured salivary gland
virus from salivary passage 1/mouse 1 for two passages in MEF,
the mutation reappeared (Fig. 4C). When we compared sali-
vary gland titers of mice infected with a Smith strain virus stock
showing an MCK-2 mixture phenotype like Smith strain Mu-
nich with pSM3fr-derived virus, we observed only slightly
higher salivary gland titers for the Smith strain (Fig. 4D). This
was in accordance with the dominance of the MCK-2 mutation
in this virus mixture, and it strongly supported our hypothesis
that the salivary gland phenotype of pSM3fr-derived virus can
be completely attributed to the MCK-2 mutation.
In addition, we sequenced BAC-derived clonal MCMV to
exclude the possibility that the MCK-2 gene locus is unstable in
E. coli or during cell culture propagation. To this end, we
isolated DNA from several pSM3fr-derived mutants and virus
progeny derived from these mutants and amplified the rel-
evant MCK-2 sequence by PCR. For all BAC mutants that
FIG. 3. Infection of BALB/c mice with virus derived from pSM3fr or pSM3fr-MCK-2fl clone 3.3 or 4.1. (A) Virus titers in the spleen, liver,
lungs, and salivary glands of BALB/c mice injected i.p. with 3  105 TCID50 of pSM3fr (pSM) (open circles) or pSM3fr-MCK-2fl clone 3.3 (gray
circles) or 4.1 (black circles). The organs were harvested on days 3, 8, and 14 postinfection (p.i.). (B) Virus titers in salivary glands of BALB/c mice
infected with pSM3fr (pSM) (open circles) or pSM3fr-MCK-2fl clone 3.3 (gray circles) or 4.1 (black circles) via the footpad or i.v. with 1.5  106
and 3  105 TCID50, respectively. The organs were harvested on day 8 and 14 p.i. Each circle shows the value for an individual mouse, and mean
values for the groups of mice are indicated by the short horizontal bars. The broken lines indicate the detection limit. nd, not determined.
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had undergone several rounds of BAC mutagenesis in E.
coli and all virus progeny of these mutants that had been
passaged either in cell culture (at least 3 passages) or were
derived from the salivary glands of infected mice, the
MCK-2 sequences were absolutely stable, preserving either
the mutation (pSM3fr-derived DNA or virus) or the repaired
MCK-2 sequence (DNA or virus derived from pSM3fr-MCK-
2fl clones) (data not shown).
When we sequenced cell culture-derived Smith strain, se-
quence mixtures were detected for only the MCK-2 gene and
for none of the other sequences amplified (primers listed in
Table 1) (data not shown). To find out whether the appearance
of mixtures of MCK-2 sequences after cell culture passage
is due to a specific property of genome position 187786 or
whether it reflects a property of the MCK-2 gene, we se-
quenced the complete MCK-2 ORF, including the intron of
FIG. 4. Cell culture-passaged MCMV Smith strain exhibits mixtures of MCK-2 wild-type and mutant genomes. (A) The locus of the MCK-2
gene spanning the pSM3fr base pair deletion was amplified from two MCMV Smith virus stocks by PCR, and the PCR products were sequenced.
The electropherograms indicate that with respect to nucleotide position 486 of MCK-2, the stocks are mixtures. For each stock, the more abundant
sequence is depicted above the electropherogram and the less abundant sequence is indicated below the electropherogram. The 533 orientation
respective to the MCK-2 ORF and nucleotide position 486 (Fig. 1) are indicated. The sequence resulting in a full-length MCK-2 ORF contains
a T enclosed in a red box. The sequencing direction is indicated by the white open arrow. (B) Suppression of the mutant population by passage
of cell culture-derived MCMV Smith strain in salivary glands. Three BALB/c mice (animals 1, 2, and 3) were injected i.p. with 2  105 TCID50
cell culture-passaged Smith strain, and the salivary glands were harvested on day 14 p.i. Then, salivary gland-derived virus was used for another
round of infection (animals 1, 2, and 3). Viral DNA from all salivary glands was amplified as described above for panel A and sequenced. The
electropherograms of the mutant locus are shown. (C) Salivary gland-derived virus from mouse 1 was used to infect MEF cells and passaged twice.
Viral DNA was amplified from supernatant virus and sequenced. The electropherogram of the mutant locus is shown. (D) BALB/c mice were
infected as described in the legend to Fig. 3A with cell culture-passaged Smith strain (small white squares), pSM3fr-derived virus (pSM) (open
circles), or pSM3fr-MCK-2fl clone 3.3 (small gray circles). The salivary glands were harvested on days 8 and 14 p.i. Each symbol shows the value
for an individual mouse, and mean values for the groups of mice are indicated by the short horizontal bars. The broken lines indicate the detection
limit.
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cell culture-derived Smith strain, and compared it to salivary
gland-passaged Smith strain and cell culture-derived BAC-
cloned virus. For the cell culture-passaged Smith strain, but not
for salivary gland-passaged and pSM3fr-derived virus, we could
detect not only the described subpopulations having or lacking
a T  A base pair at position 486 of MCK-2 but also another
subpopulation carrying a 9-bp deletion at the 3 end of the
intron, which would remove the splice junction and thus also
interrupt the MCK-2 ORF. Interestingly, cell culture-passaged
MCMV strain K181 also showed subpopulations carrying ei-
ther frameshifts or a base pair exchange, all of which would
result in truncated MCK-2 proteins (data not shown). Yet, a
frameshift mutation at position 486 was not found for strain
K181 (data not shown). Thus, the appearance of different
MCK-2 truncating mutations strongly suggests that a property
of MCK-2 results in selection or counterselection of genomes
carrying MCK-2-inactivating mutations in cell culture or in
salivary glands, respectively.
DISCUSSION
Cloning of herpesvirus genomes as bacterial artificial chro-
mosomes (BACs) has introduced a new and fast technique of
manipulating viral genomes in the field of herpesvirus re-
search. It allows us to mutate or to modify viral genomes in
E. coli, to reconstitute virus from these mutated genomes, and
to analyze the virus progeny in vitro and in vivo. One major
advantage of BAC cloning to classical methods based on re-
combination of viral genomes with plasmids in cells and sub-
sequent selection of recombinant viruses was the avoidance of
selection steps to separate mutant from wild-type viruses. In-
stead, during the mutagenesis procedure, truly clonal genome
progeny are created in E. coli.
Here, we sequenced the complete genomes of the Smith
strain-derived BAC pSM3fr, two mutants of this BAC and
virus progeny derived from one of the mutants, and compared
the sequences to the sequence published for MCMV Smith
strain (36). Most of the sequence deviations we observed have
been described recently for a pSM3fr-derived spontaneous
M112/113 mutant (41). We could now show that the majority
of these deviations are presumably sequence failures of the
published sequence of MCMV Smith strain. Only four of the
observed differences could not be found in Smith strain-de-
rived DNA (Table 2, group C). Thus, the sequence of the
pSM3fr-BAC is nearly identical to the sequence of the Smith
strain.
The most striking difference between the Smith strain se-
quence and the pSM3fr BAC was a mutation in the MCK-2
ORF that would truncate MCK-2. Sequencing of the MCK-2
ORF of the MCMV Smith strain and MCMV K181 strain
had shown undisrupted ORFs coding for 280-amino-acid-
long, highly conserved proteins (17, 27, 36, 43). Thus, we posed
the following two questions: is the MCK-2 mutation account-
able for the low salivary gland titers observed after infection of
BALB/c mice with pSM3fr-derived virus and how was this
mutation introduced into pSM3fr?
Mutations disrupting the MCK-2 ORF are well character-
ized, and one hallmark has been low salivary gland titers in
mice infected with these mutants (17, 39). This was also ob-
served when pSM3fr-derived viruses were characterized in vivo
(10, 12, 15, 21, 32) and stood in marked contrast to high
salivary gland titers obtained after infection with MCMV
strains not cloned as BACs (17, 22, 28, 39). We could restore
the phenotype of high virus titers in salivary glands by repairing
the pSM3fr mutation and thus provide evidence that pSM3fr-
derived virus shows an attenuated growth phenotype in salivary
glands due to a mutation in MCK-2. In accordance with earlier
publications which characterized MCK-2 deletion mutants and
showed that, independent of the route of infection, virus at-
tenuation was restricted to salivary glands (17, 39), pSM3fr-
derived attenuation was also restricted to salivary glands when
we analyzed the intraperitoneal route of infection.
Usually, publications on in vivo growth phenotypes do not
compare MCMV wild-type strain properties with growth prop-
erties of BAC-cloned viruses, and thus, the growth discrepancy
between wild-type virus and pSM3fr-derived virus was never
revealed. Additionally, as we could show here, cell culture-
passaged Smith strain usually is a mixture containing genomes
with intact and mutant MCK-2 ORFs, and depending on the
proportion of mutant genomes, salivary gland virus titers will
probably not differ from titers achieved by pSM3fr-derived
virus. Interestingly, we observed that in vivo passage in salivary
glands suppressed detectable populations of mutant MCK-2
sequences, which quickly reappeared when virus was recul-
tured in cells. This fast switch reminds us of earlier publica-
tions showing a loss of virulence of MCMV Smith strain after
cell culture passage and an increase in virulence for salivary
gland-derived virus (24, 34). Whether Smith strain virulence, as
defined for example by 50% lethal dose (LD50) values for
survival of infected newborn mice, and MCK-2 mutations cor-
relate will have to be determined in the future.
The MCK-2 locus of MCMV Smith strain has been sequenced
before from PCR-amplified genomic fragments, but neither
mixed populations nor mutations interrupting the MCK-2
ORF have been described (43). One reason might be that
plaque purified virus was used instead of unpurified superna-
tant virus, and thus, the virus progeny of a single “MCK-2
genotype” were selected. It is striking that the MCK-2 se-
quence populations which we observed for cell culture-pas-
saged Smith or K181 strain all consisted of mutations inter-
rupting the MCK-2 ORF. Our data imply that salivary gland
passage selects nonmutated virus, which could be explained by
the reduced titers of MCK-2 mutants in salivary glands. Yet,
our data also imply that cell culture passage selects the mutant
phenotype, although wild-type and mutant viruses replicate
equally well in cell culture (Fig. 2). The fast switch in the
relative proportions of mutant and wild-type sequences sug-
gests that the mutations are preexisting in the virus prepara-
tions and become visible or disappear depending on whether
the virus is replicating in cell culture or in mice. It is notewor-
thy that mixed sequences only become apparent in electro-
pherograms when at least 10% of the sequences are aberrant.
In contrast to the wild-type MCMV strains, passage of BAC-
cloned viruses, either in cell culture or in mice, neither re-
versed the MCK-2 mutation nor introduced new mutations
(data not shown). Thus, the pSM3fr-MCK-2fl-derived viruses
might be an alternative to salivary gland-derived virus for in-
fection of mice.
BAC cloning is usually done using virus isolates. Yet, cyto-
megalovirus (CMV) isolates for example are consistently
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found to be mixtures of different genotypes (7, 18, 20, 31, 42,
43). Due to clonal propagation steps in E. coli, BAC cloning of
viral genomes will automatically result in selection of a single
genotype from a mixture, which might have a different pheno-
type than the genotypically heterogeneous parental virus iso-
late. We therefore propose to sequence each BAC-cloned ge-
nome to determine its specific genotype, a practice which has
been followed in the last years for many BAC-cloned human
CMVs (33, 42, 44).
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